Please select the eligibility criteria that correspond to the clinical trial below.
Title: CBT for Anxiety Disorders in Autism: Adapting Treatment for Adolescents
Brief Summary: Comorbid anxiety disorders affect as many as 80% of youth with autism spectrum disorders, causing substantial distress and impairment over and above the autism spectrum diagnosis alone. Cognitive behavioral therapy (CBT) is the gold standard treatment among typically developing youth with an anxiety disorder and when adapted, shows promise in children with ASD and comorbid anxiety. However, there is currently no psychotherapy protocol tailored to meet the unique needs of young adolescents with Autism spectrum disorders (ASD) and comorbid anxiety. Given this, the present study seeks to develop and test a new CBT therapy in adolescents with autism and comorbid anxiety.


Options:
A: Inclusion Criteria:

* Primary diagnosis of SAD
* Age 5 to 13 years
* Knowledge of German language
* Consent to randomization and psychological testing

Exclusion Criteria:

* Comorbid Pervasive Developmental Disorders
* Active psychotropic drugs
B: Inclusion Criteria:

* Outpatient adolescents with ASD (see below) between the ages 11-14 years.
* Meets criteria for a diagnosis of autism, Asperger syndrome (AS), or Pervasive Developmental Disorder Not Otherwise Specified .
* Meets criteria for a diagnosis of one of the following anxiety disorders: separation anxiety disorder (SAD), generalized anxiety disorder (GAD), social phobia, or obsessive compulsive disorder (OCD).
* Child has a Full Scale and Verbal Comprehension IQ≥85.

Exclusion Criteria:

* Receiving concurrent psychotherapy, social skills training, or behavioral interventions (e.g., applied behavior analysis). Families will have the option of discontinuing such services to enroll in the study.
* Has started an antidepressant within 12 weeks before study enrollment or an antipsychotic 6 weeks before study enrollment.
* Has changed established psychotropic medications (e.g., antidepressants, anxioloytics) within 8 weeks before study enrollment (6 weeks for antipsychotic).
* Is currently suicidal or has been actively suicidal in the last 6 months.
* Has been diagnosed with bipolar, schizophrenia or schizoaffective disorders; or Substance abuse in past 6 months.
* Presence of a significant and/or unstable medical illness which might lead to hospitalization during the study.
C: Inclusion Criteria:

* 7 - 13 year olds and their parents
* seeking services at community mental health clinics
* primary problem or disorder related to anxiety, depression, or conduct problems

Exclusion Criteria:

* Child is younger than 7 years, 9 months or older than 13 on the day of the phone screen.
* Child has attempted suicide within the past year.
* Schizophrenic spectrum diagnosis (including MDD w/ psychotic features)
* Autism or another Pervasive Developmental Disorder (e.g., PDD NOS, Asperger's Disorder, Child Disintegrative Disorder, Rett's Disorder).
* Anorexia Nervosa
* Bulimia Nervosa
* Mental Retardation
* No relevant T-scores validate target disorders.
* ADHD identified as primary reason for seeking treatment at phone screen
* Child's sibling already included
* Child's medication has not been regulated for one month or longer
D: Inclusion Criteria:

1. Diagnosis. DSM-IV primary diagnosis (most severe) of social anxiety disorder (as determined by the ADIS-PC)
2. Age and Sex. Boys and Girls, 14 through 19 years
3. Grade. 9th, 10th, 11th, or 12th
4. English speaking. Adolescent

Exclusion Criteria:

1. Current diagnosis of substance use or conduct disorder
2. Concurrent mental disorder of greater severity than social anxiety disorder
3. Current psychotic symptoms
4. Current suicidal ideation
5. Pervasive developmental disorder, or a significant medical disorder (e.g., substantially impairs functioning, school attendance, or the ability to engage in treatment)
6. Current psychological or pharmacological treatment

Answer: B